Go beyond in single cell manipulation
Gentle and accurate single-cell injection and cytoplasmic biopsies.
Solutions
Explore cellular heterogeneity with this unique manipulation capability down to the single cell. The FluidFM technology - the FluidFM OMNIUM, the instrument and the CellEDIT service - allow to precisely, inject into and extract from a broad range of cell types and applications, without compromising cell viability.

CRISPR Gene Editing
Find out more about the FluidFM workflow for precision CRISPR genome engineering.

Single-Cell Profiling
Explore the potential use of the FluidFM for temporal transcriptomics.

Molecular Biology
Discover the single-cell biopsy capabilities to support single-cell RNA sequencing.

Mechanobiology
Measure cell adhesion with the FluidFM technology in native environment.
Two ways to work with us
FluidFM® OMNIUM
Instrument & ADD-ON for single-cell manipulation.
Stand-alone
Semi-automated
Versatile
CellEDIT Service
CRISPR Cell Line Editing Service
Monoclonal Cell Line
Hard-to-transfect mammalian cells
Complex Edits
Knowledge Center
Discover all the resources available to provide you with key knowledge related to Life Science and Biology!
Publications
Explore 100+ publications in which FluidFM technology plays a major role. 8+ Ø impact factor.
Blog
Interesting insights on the company, applications, or persons working with FluidFM technology.
About Us
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting edge solutions based on its patented FluidFM ® technology.
By uniting the best features of microfluidics and force microscopy, Cytosurge provides innovative products and services to shift boundaries in single-cell gene engineering and omics. The Cytosurge vision into the future is to contribute to human wellbeing through advancements in single cell technologies.